Amundi’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-201,366
Closed -$16M 2264
2024
Q4
$16M Sell
201,366
-23,076
-10% -$1.13M 0.01% 763
2024
Q3
$9.52M Sell
224,442
-21,503
-9% -$1.03M ﹤0.01% 857
2024
Q2
$12.3M Buy
245,945
+8,991
+4% +$399K ﹤0.01% 792
2024
Q1
$9.16M Sell
236,954
-8,714
-4% -$465K ﹤0.01% 857
2023
Q4
$14.5M Buy
245,668
+10,507
+4% +$633K 0.01% 767
2023
Q3
$13M Buy
235,161
+1,642
+0.7% +$103K 0.01% 783
2023
Q2
$13.2M Sell
233,519
-14,181
-6% -$895K 0.01% 787
2023
Q1
$15.9M Sell
247,700
-4,744
-2% -$285K 0.01% 740
2022
Q4
$16.8M Buy
252,444
+9,868
+4% +$716K 0.01% 744
2022
Q3
$18.2M Sell
242,576
-5,533
-2% -$412K 0.01% 717
2022
Q2
$18.2M Sell
248,109
-23,027
-8% -$1.65M 0.01% 646
2022
Q1
$24.2M Buy
271,136
+94,188
+53% +$7.71M 0.02% 611
2021
Q4
$14.3M Buy
176,948
+7,142
+4% +$612K 0.01% 758
2021
Q3
$13.8M Sell
169,806
-3,037
-2% -$255K 0.01% 767
2021
Q2
$16.1M Buy
+172,843
New +$16.8M 0.01% 725

Other funds holding NARI

Amundi's NARI Position: Q1 2025 in Review

Amundi sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 201,366 shares — an estimated $16M sold.

Amundi first reported a position in NARI in Q2 2021 and held it in 15 quarters. The position peaked at $24.2M in Q1 2022. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Amundi reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Amundi sold 201,366 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $16M.
  • Amundi first reported a position in Inari Medical, Inc. Common Stock in Q2 2021 and held it in 15 quarters.
  • Amundi's Inari Medical, Inc. Common Stock position peaked at $24.2M in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Amundi's 13F filing for Q1 2025, filed 15 May 2025.